Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Guardant Health Inc (GH)

478 + Investors. Track Smart Money conviction in GH. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -10
Streak
1Q ▼
Buyers last Q
52%

Smart Money Signals — GH

Based on 482 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their GH positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🏔️

At the ownership peak (98% of max)

98% of all-time peak
482 hedge funds hold GH right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +43% more funds vs a year ago

fund count last 6Q
+145 new funds entered over the past year (+43% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 52% buying

266 buying246 selling
Last quarter: 266 funds bought or added vs 246 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-68 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 67 → 68 → 142 → 74. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

49% of holders stayed for 2+ years

■ 49% conviction (2yr+) ■ 23% medium ■ 29% new
235 out of 482 hedge funds have held GH for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
🚀

Acceleration phase — new buyers rushing in

88 → 67 → 68 → 142 → 74 new funds/Q
New funds entering each quarter: 67 → 68 → 142 → 74. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 60% veterans vs 33% newcomers

■ 60% veterans ■ 7% 1-2yr ■ 33% new
Entry-cohort mix of 500 holders: 302 (60%) are 2+ year veterans, 34 entered 1–2 years ago, and 164 (33%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 42% AUM from top-100 funds

42% from top-100 AUM funds
60 of 478 holders are among the 100 largest funds by AUM, controlling 42% of total institutional value in GH. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.3
out of 10
Moderate Exit Risk
Exit risk score 4.3/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — GH

In 2026 Q1, 266 hedge funds were net buyers of GH (74 opened a new position, 192 added to an existing one), while 246 reduced or exited (162 trimmed, 84 sold completely) — a 52% buyer ratio, indicating a slight buying edge. 42% of total institutional value in GH is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -10 funds (more exits than new entries). Total institutional holders: 482.

Hedge Fund Ownership: GH

How many hedge funds hold GH — quarterly history vs. share price
Quarterly hedge fund ownership of GH vs. share price

Market Analysis: GH

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: GH

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Guardant Health Inc (GH) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much GH has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 78d ago
GH
+40.5%
XLV
+3.1%

GH outperformed XLV by +37.4% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 33d ago
GH
+36.8%
XLV
+4.2%

Since the filing became public, GH outperformed XLV by +32.6% .

Interpretation: The stock has significantly outperformed its sector benchmark — the original entry opportunity has largely been captured by earlier investors. Learn more →

Smart Money Signal ?
Broad Consensus, Selective Conviction

Many quality funds hold this stock, but top-tier positions remain relatively small.

40 top-rated funds 5 high-conviction
Consensus
7.0
/ 10
breadth
×
Elite
4.5
/ 10
conviction
Hedge Fund Positioning: GH
478 + Investors

Track Smart Money conviction in GH. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 478 492 -2.85%
13F Shares 141M 134M 5.16%
Total Value $11.94B $13.11B -8.96%
New Positions 72 142 -70
Increased Positions 187 154 +33
Closed Positions 86 39 +47
Reduced Positions 157 148 +9
Total Calls 10 15 -33.33%
Total Puts 12 13 -7.69%
PUT/CALL Ratio 1.2 0.87 Neutral

Statistics: GH

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

478 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in GH. Verified SEC 13F-HR filings.

QUARTER:
Top 25 GH holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Blue Water Life Science Advisors, LP 17.94% 242,247 $22.4M
2 Cadian Capital Management, LP 8.77% 779,648 $72.0M
3 Sicart Associates LLC 5.46% 230,103 $21.3M
4 Deep Track Capital, LP 5.04% 3,338,241 $308.4M
5 Eagle Health Investments LP 5.01% 310,281 $28.7M
6 Exome Asset Management LLC 3.95% 82,736 $7.6M
7 Eventide Asset Management, LLC 3.61% 2,362,379 $218.1M
8 Adalta Capital Management LLC 2.72% 61,473 $5.7M
9 Emerald Advisers, LLC 2.46% 841,917 $77.8M
10 Emerald Mutual Fund Advisers Trust 2.33% 519,545 $48.0M
11 First Light Asset Management, LLC 2.32% 280,299 $25.9M
12 Casdin Capital, LLC 2.20% 315,000 $29.1M
13 Summit Partners Public Asset Management, LLC 2.14% 862,915 $79.7M
14 Lagoda Investment Management, L.P. 2.07% 36,410 $3.4M
15 Styrax Capital, LP 1.94% 300,000 $27.7M
16 Aristotle Atlantic Partners, LLC 1.93% 445,530 $41.2M
17 SWS Partners 1.81% 79,481 $7.3M
18 Rhenman & Partners Asset Management AB 1.65% 145,000 $13.4M
19 Braidwell LP 1.54% 499,712 $46.2M
20 Future Fund LLC 1.51% 46,465 $4.3M
21 Rtw Investments, LP 1.36% 1,481,033 $136.8M
22 Hood River Capital Management LLC 1.21% 1,310,065 $121.0M
23 Atika Capital Management LLC 1.06% 91,000 $8.4M
24 Driehaus Capital Management LLC 1.03% 1,524,282 $140.8M
25 Values First Advisors, Inc. 1.00% 20,765 $1.9M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Guardant Health Inc (GH)

What does the Smart Money Trend signal show for GH?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their GH positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for GH?

Slight buying edge — 52% buying: Last quarter: 266 funds bought or added vs 246 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for GH holders?

Elite ownership — 42% AUM from top-100 funds: 60 of 478 holders are among the 100 largest funds by AUM, controlling 42% of total institutional value in GH. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held GH?

49% of holders stayed for 2+ years: 235 out of 482 hedge funds have held GH for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Guardant Health Inc (GH) following the 2026 Q1 hedge fund 13F filings?

As of today, GH has moved +36.8% since the 2026 Q1 13F filing date (May 15, 2026), compared to +4.2% for the XLV sector ETF — an outperformance of +32.6%. Since the quarter end (March 31, 2026), GH has gained +40.5% vs +3.1% for XLV. The stock has significantly outperformed its sector benchmark — the original entry opportunity has largely been captured by earlier investors.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →